Videos

Neurology Grand Rounds at the University of Minnesota Medical School - Richard K Burt MD, Feinberg School of Medicine, Northwestern University - February 22, 2019.

This video is about Haemopoietic stem cell transplantation in the management of multiple sclerosis.

Autologous Hematopoietic Stem Cell Transplant is a treatment for autoimmune diseases such as MS-Multiple Sclerosis (SPMS), (PPMS) or (RRMS), Scleroderma, Type I Diabetes, CIDP-Chronic Inflammatory Demyelinating Polyneuropathy, TM-Transverse Myelitis or NMO-Neuromyelitis Optica, that has scientifically proven to halt the disease progression. Hematopoietic stem cells are used to restore the normal hematopoiesis of the patient after being exposed to high dose chemotherapy delivered to aim immunosuppression.

• Website: https://www.hsctmexico.com/
• Apply now: https://www.hsctmexicoprogram.com/
• Facebook: https://www.facebook.com/HSCTMexico/

2018 Fall Patient Education Conference
Hematopoietic Stem Cell Transplantation

Richard Burt, MD
Chief of Immunotherapy and Autoimmune Diseases, Professor of Medicine, Division of Immunotherapy and Autoimmune Diseases; Northwestern University, Feinberg School of Medicine, Chicago, IL

Presented at the Scleroderma Patient Education Conference 2018.

Hosted by the Scleroderma Foundation Greater Chicago Chapter.

More Information on Official Website and YouTube: www.scleroderma.org/chicago

Dr. Daniel Kantor, Shirley Nedzesky, & Wendy Booker speak with Mark Freedman from the University of Ottowa about the current status of Stem Cell research in the field of Multiple Sclerosis.

Dr. Richard Burt of Northwestern University, Chicago at the Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on 18-21 March 2018 held at Lisbon, Portugal.

Day 3 Presentation titled: A Hitchhiker Guide to HSCT for Autoimmune Disease: Don't Panic Multiple Sclerosis

Dr. Richard Burt of Northwestern University, Chicago at the Annual Meeting of the European Society for Blood and Marrow Transplantation on 18-21 March 2018 held at Lisbon, Portugal.

Day 1 Presentation titled: Non-Myeloablative Haematopoietic Stem Cell Transplantation Versus Continued Disease Modifying Therapies (DMT) in Patients With Highly Active Relapsing Remitting Multiple Sclerosis (RRMS)

Richard K Burt, Roumen Balabanov, John A Snowden, Basil Sharrack, Maria Carolina Oliveira, Flavia Nelson, Joachim Burman (United States)

Dr. Richard Burt of Northwestern University, Chicago received Van Bekkum Award at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on 18-21 March 2018 held at Lisbon, Portugal. The Van Bekkum Award is the most prestigious EBMT award for the best abstract submitted to the physician's programme and is selected by the EBMT Board. The winning abstract will be presented as part of the Opening Session of the Meeting.

Cellular Horizons: How Science , Technology, Information and Communication Will Impact Society, Vatican City, April 28-30, 2016.

Day 2: Cellular and Technological Breakthroughs in Cancer, April 29, 2016.

Sanjay Gupta, MD, moderates a discussion with Richard K. Burt, MD, Chief of the Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, and two of his patients, Elizabeth Cougentakis and Grace Meihaus.